The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter
Open accessAbstract
Antibiotics changed medical practice by significantly decreasing the morbidity and mortality associated with bacterial infection. However, infectious diseases remain the leading cause of death in the world. There is global concern about the rise in antimicrobial resistance (AMR), which affects both developed and developing countries. AMR is a public health challenge with extensive health, economic, and societal implications. This paper sets AMR in context, starting with the history of antibiotics, including the discovery of penicillin and the golden era of antibiotics, before exploring the problems and challenges we now face due to AMR. Among the factors discussed is the low level of development of new antimicrobials and the irrational prescribing of antibiotics in developed and developing countries. A fundamental problem is the knowledge, attitude, and practice (KAP) regarding antibiotics among medical practitioners, and we explore this aspect in some depth, including a discussion on the KAP among medical students. We conclude with suggestions on how to address this public health threat, including recommendations on training medical students about antibiotics, and strategies to overcome the problems of irrational antibiotic prescribing and AMR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–253 of 253
Current concepts in antibiotic-resistant Gram-negative bacteria
Torres, J. A., Villegas, M. V., & Quinn, J. P. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.5.833 · Cited by 67
Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens
Bonomo, R. A. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz823 · Cited by 65
Abraham, E. P. (1987) · Drugs · doi:10.2165/00003495-198700342-00003 · Cited by 63
Medicines Information and the Regulation of the Promotion of Pharmaceuticals
Alves, T. L., Lexchin, J., & Mintzes, B. J. (2018) · Science and Engineering Ethics · doi:10.1007/s11948-018-0041-5 · Cited by 63
The determinants of the antibiotic resistance process
Espinosa, B. (2009) · Infection and Drug Resistance · doi:10.2147/idr.s4899 · Cited by 63
Further observations on penicillin. 1941.
Abraham, E. P., Chain, E. B., Cm, F., Florey, H. W., Ad, G., HEATLEY, N. G., & Ma, J. (1992) · PubMed · Cited by 62
When will the genomics investment pay off for antibacterial discovery?
Mills, S. D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.11.025 · Cited by 58
Obtaining antibiotics online from within the UK: a cross-sectional study
Boyd, S. E., Moore, L. S. P., Gilchrist, M. J., Costelloe, C., Castro‐Sánchez, E., Franklin, B. D., & Holmes, A. H. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx003 · Cited by 58
Bakhit, M., Mar, C. D., Gibson, E. M., & Hoffmann, T. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026735 · Cited by 58
Dang-Van, A., Tiraby, G., Acar, J. F., Shaw, W. V., & Bouanchaud, D. H. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.13.4.577 · Cited by 56
Torres, A., Rank, D., Melnick, D., Rekeda, L., Chen, X., Riccobene, T. A., Critchley, I. A., Lakkis, H. D., Taylor, D., & Talley, A. K. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz149 · Cited by 56
Assessing prescribing competence
Mucklow, J. C., Bollington, L., & Maxwell, S. R. J. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04151.x · Cited by 53
Invisible medicine sellers and their use of antibiotics: a qualitative study in Cambodia
Suy, S., Rego, S., Bory, S., Chhorn, S., Phou, S., Prien, C., Heng, S., Wu, S., Legido‐Quigley, H., Hanefeld, J., et al. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2019-001787 · Cited by 53
Garau, J., Wilson, W. R., Wood, M., & Carlet, J. M. (1997) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1997.tb00649.x · Cited by 52
Chalker, J. C., Vialle-Valentin, C. E., Liana, J., Mbwasi, R., Semali, I. A., Kihiyo, B., Shekalaghe, E., Dillip, A., Kimatta, S. S., Valimba, R., et al. (2015) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-015-0075-2 · Cited by 52
Roh, H., Cho, S.-Y., & So, W.-Y. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15040757 · Cited by 49
Infectious Diseases Society of America (2008) · Clinical Infectious Diseases · doi:10.1086/591411 · Cited by 48
Infections, F. O. E. (2003) · Cited by 48
Bbosa, G. S., Wong, G., Kyegombe, D. B., & Ogwal-Okeng, J. W. (2014) · Health · doi:10.4236/health.2014.62027 · Cited by 47
Redfern, J., Bowater, L., Coulthwaite, L., & Verran, J. (2020) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaa012 · Cited by 46
Novel Strategies to Combat Antimicrobial Resistance
Kaur, I. (2016) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000292 · Cited by 45
Wallenfels, K. (1945) · Angewandte Chemie · doi:10.1002/ange.19450580102 · Cited by 43
Jacobs, M. R. (2007) · Future Microbiology · doi:10.2217/17460913.2.6.591 · Cited by 41
Minzi, O., & Manyilizu (2013) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s36409 · Cited by 40
Chan, W. C., Li, R. C., Ling, J., Cheng, A. F., & Schentag, J. J. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.1.55 · Cited by 39
Antimicrobial agents – optimising the ecological balance
Woon, S.-A., & Fisher, D. A. (2016) · BMC Medicine · doi:10.1186/s12916-016-0661-z · Cited by 39
Improving antibiotic prescribing skills in medical students: the effect of e-learning after 6 months
Sikkens, J. J., Caris, M. G., Schutte, T., Kramer, M. H. H., Tichelaar, J., & van Agtmael, M. A. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky163 · Cited by 38
What Is an Antibiotic? Revisited
Bentley, R., & Bennett, J. W. (2003) · Advances in applied microbiology · doi:10.1016/s0065-2164(03)01012-8 · Cited by 34
Schlesinger, M. J., Quon, N., Wynia, M. K., Cummins, D., & Gray, B. H. (2005) · Health Services Research · doi:10.1111/j.1475-6773.2005.00377.x · Cited by 34
Telavancin: A novel lipoglycopeptide antibiotic
Damodaran, S. E., & Madhan, S. (2011) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.81918 · Cited by 33
Combatting Antibiotic Resistance Together: How Can We Enlist the Help of Industry?
Edwards, S. E., Morel, C. M., Busse, R., & Harbarth, S. (2018) · Antibiotics · doi:10.3390/antibiotics7040111 · Cited by 33
Hassali, M. A. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/6199.3923 · Cited by 32
Self-citationRifampicin mono-resistant tuberculosis in France: a 2005–2010 retrospective cohort analysis
Meyssonnier, V., Bui, T. V., Véziris, N., Jarlier, V., & Robert, J. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-18 · Cited by 31
Overcoming the challenges to developing new antibiotics
Shlaes, D. M., & Spellberg, B. J. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.06.010 · Cited by 30
Cefepime-ResistantPseudomonas aeruginosa
Akhabue, E., Synnestvedt, M. B., Weiner, M. G., Bilker, W. B., & Lautenbach, E. (2011) · Emerging infectious diseases · doi:10.3201/eid/1706.100358 · Cited by 29
Paterson, D. L. (2002) · Seminars in Respiratory Infections · doi:10.1053/srin.2002.36446 · Cited by 28
Sharma, S., Jayakumar, D., Palappallil, D. S., & Kesavan, K. P. (2016) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20161542 · Cited by 28
Haque, M. (2017) · Journal of International Society of Preventive and Community Dentistry · doi:10.4103/jispcd.jispcd_224_17 · Cited by 28
Self-citationDoes perverse economic incentive lead to the irrational uses of medicines?
Mao, W., Tang, S., & Chen, W. (2013) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2013.856266 · Cited by 25
Activity of ampicillin in vitro compared with other antibiotics
Sutherland, R., & Rolinson, G. N. (1964) · Journal of Clinical Pathology · doi:10.1136/jcp.17.4.461 · Cited by 24
Decrease in Penicillin Sales in Brazil after Over-the-Counter Restrictions
Lopes-Júnior, R., Fiol, F. D. S. D., Araujo, J. L. O., de Toledo, M. I., & Barberato-Filho, S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01030-15 · Cited by 17
Corruption practices in drug prescribing in Vietnam – an analysis based on qualitative interviews
Nguyen, T. A., Knight, R., Mant, A., Razee, H., Brooks, G., Dang, T. H., & Roughead, E. E. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3384-3 · Cited by 17
Gama, A. S. M., Figueras, A., & Secoli, S. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201579 · Cited by 17
Ncube, N. B. Q., Knight, L., Bradley, H., Schneider, H. M., & Laing, R. O. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235513 · Cited by 13
Saleem, Z., Hassali, M. A., Hashmi, F. K., Azhar, F., Mubarak, R., Afzaal, A., & Munawar, U. (2019) · Pharmacy Education · Cited by 10
Self-citationGood prescribing to maximize patient benefit
Haque, P. M. (2018) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/ijnpnd.ijnpnd_31_18 · Cited by 5
McLean, M. M., Köhler, J. C., & Edwards, D. (2019) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-019-0187-9 · Cited by 4
Drug promotional literatures: Educative or misleading for young medical graduates and students?
Abubakar, A. R., Sheikh, S., & Haque, M. (2015) · National Journal of Physiology Pharmacy and Pharmacology · doi:10.5455/njppp.2015.5.1205201548 · Cited by 3
Self-citationFuture Medical Doctors Are Ready to Prescribe Antimicrobials Safely and Rationally
Haque, M. (2017) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i12.21930 · Cited by 3
Self-citationDecrease in Antibiotic Sales in Brazil After New Control Legislation
Slain, D., Lopes-Júnior, R., de Toledo, M. I., Fiol, F. D. S. D., & Barberato-Filho, S. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx162.146 · Cited by 2
Kabani, A. M., Joffe, A. R., Cadrain, G., & Jadavji, T. (1990) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/1990/691734 · Cited by 1
The Present Century. The Beginnings of Preventive Medicine
Mann, R. D. (1984) · Springer eBooks · doi:10.1007/978-94-009-5586-8_7 · Cited by 1
(2013) · PubMed Central
Cited by
Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023) · Pharmaceuticals · doi:10.3390/ph16111615 · Cited by 1,215
Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
Majumder, M. A. A., Rahman, S., Cohall, D., Bharatha, A., Singh, K., Haque, M., & Gittens-St Hilaire, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s290835 · Cited by 633
Self-citationAntimicrobial research productivity in Lebanon: A PubMed-Based bibliometric analysis
Hajj, A., Sacre, H., Ounsi, M., Nasser, M., Mohsen Meame, S., Hazime, H., Al-Hajje, A., Rahme, D., Lahoud, N., Safwan, J., et al. (2025) · New Microbes and New Infections · doi:10.1016/j.nmni.2025.101642 · Cited by 1
Metadata
- Authors
- Dhingra, S., Rahman, N. A. A., Peile, E., Rahman, M., Sartelli, M., Hassali, M. A., Islam, T., Islam, S., & Haque, M.
- Venue
- Frontiers in Public Health
- Publisher
- Frontiers Media SA
- Published
- 2020-11-04
- Volume
- 8
- Pages
- 535668-535668
- ISSN
- 2296-2565 (ISSN-L)
- OpenAlex
- W3097070695
- Cited by
- 329
- References
- 253
- FWCI
- 21.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.